Pier Capital, LLC Maxcyte, Inc. Transaction History

Pier Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$4.92 - $7.4 $927,370 - $1.39 Million	-188,490 Reduced 14.93%	1,074,164 $5.86 Million
Q3 2022 Nov 15, 2022	SELL	$4.52 - $6.51 $464,515 - $669,026	-102,769 Reduced 7.53%	1,262,654 $8.21 Million
Q2 2022 Aug 15, 2022	BUY	$3.59 - $6.81 $1.25 Million - $2.37 Million	347,670 Added 34.16%	1,365,423 $6.46 Million
Q1 2022 May 10, 2022	SELL	$5.26 - $10.84 $34,179 - $70,438	-6,498 Reduced 0.63%	1,017,753 $7.11 Million
Q4 2021 Feb 10, 2022	BUY	$8.87 - $12.94 $4.75 Million - $6.93 Million	535,578 Added 109.6%	1,024,251 $10.4 Million
Q3 2021 Nov 10, 2021	BUY	$12.21 - $17.2 $5.97 Million - $8.41 Million	488,673 New	488,673 $5.97 Million

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.